▶ 調査レポート

世界の店頭(OTC)医薬品&栄養補助食品市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Over the Counter (OTC) Drugs & Dietary Supplements Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

が調査・発行した産業分析レポートです。世界の店頭(OTC)医薬品&栄養補助食品市場 2021:企業別、地域別、種類・用途別 / Global Over the Counter (OTC) Drugs & Dietary Supplements Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-105X13120資料のイメージです。• レポートコード:GIR-105X13120
• 出版社/出版日: / 2021年5月
• レポート形態:英文、PDF、137ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:Pharma & Healthcare
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、店頭(OTC)医薬品&栄養補助食品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。店頭(OTC)医薬品&栄養補助食品の種類別市場規模(鎮痛剤、皮膚科製品、咳、風邪、インフルエンザ製品、ビタミンサプリメント、ミネラルサプリメント、眼科製品)、用途別市場規模(薬局、食料品店、ビタミン、健康食品店、オンライン薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・店頭(OTC)医薬品&栄養補助食品の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Pfizer Inc.、Novartis International AG、Roche Holding AG、Merck & Co., Inc.、Sanofi S.A、Johnson & Johnson、Gilead Sciences、GlaxoSmithKline plc.、Bayer Healthcare AG、AstraZeneca plc.、Alacer Corp.、Alcon Inc.、Alfresa Pharma Corporation、Alkalon A/S、Alliance Healthcare、Allergan, Plc.、Reckitt Benckiser Plc.、Bausch & Lomb、AbbVie Inc.、The Colgate-Palmolive Company
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:鎮痛剤、皮膚科製品、咳、風邪、インフルエンザ製品、ビタミンサプリメント、ミネラルサプリメント、眼科製品
・用途別分析2016年-2026年:薬局、食料品店、ビタミン、健康食品店、オンライン薬局
・店頭(OTC)医薬品&栄養補助食品の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・店頭(OTC)医薬品&栄養補助食品のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・店頭(OTC)医薬品&栄養補助食品のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・店頭(OTC)医薬品&栄養補助食品の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・店頭(OTC)医薬品&栄養補助食品の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Over the Counter (OTC) Drugs & Dietary Supplements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Over the Counter (OTC) Drugs & Dietary Supplements size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Over the Counter (OTC) Drugs & Dietary Supplements market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Over the Counter (OTC) Drugs & Dietary Supplements market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Analgesic & pain relievers
Dermatological products
Cough, cold, and flu products
Vitamin supplements
Mineral Supplements
Ophthalmic Products

Market segment by Application can be divided into
Pharmacies
Grocery Stores
Vitamin
Health Food Stores
Online Pharmacies

The key market players for global Over the Counter (OTC) Drugs & Dietary Supplements market are listed below:
Pfizer Inc.
Novartis International AG
Roche Holding AG
Merck & Co., Inc.
Sanofi S.A
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline plc.
Bayer Healthcare AG
AstraZeneca plc.
Alacer Corp.
Alcon Inc.
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan, Plc.
Reckitt Benckiser Plc.
Bausch & Lomb
AbbVie Inc.
The Colgate-Palmolive Company

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Over the Counter (OTC) Drugs & Dietary Supplements Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Analgesic & pain relievers
1.2.3 Dermatological products
1.2.4 Cough, cold, and flu products
1.2.5 Vitamin supplements
1.2.6 Mineral Supplements
1.2.7 Ophthalmic Products
1.3 Market Analysis by Application
1.3.1 Overview: Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pharmacies
1.3.3 Grocery Stores
1.3.4 Vitamin
1.3.5 Health Food Stores
1.3.6 Online Pharmacies
1.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size & Forecast
1.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales in Value (2016-2026))
1.4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales in Volume (2016-2026)
1.4.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Type (2016-2026) & (USD/MT)
1.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Production Capacity Analysis
1.5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Total Production Capacity (2016-2026)
1.5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
1.6.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
1.6.3 Over the Counter (OTC) Drugs & Dietary Supplements Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis International AG
2.2.1 Novartis International AG Details
2.2.2 Novartis International AG Major Business
2.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.2.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Roche Holding AG
2.3.1 Roche Holding AG Details
2.3.2 Roche Holding AG Major Business
2.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.3.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Merck & Co., Inc.
2.4.1 Merck & Co., Inc. Details
2.4.2 Merck & Co., Inc. Major Business
2.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sanofi S.A
2.5.1 Sanofi S.A Details
2.5.2 Sanofi S.A Major Business
2.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.5.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.6.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Gilead Sciences
2.7.1 Gilead Sciences Details
2.7.2 Gilead Sciences Major Business
2.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.7.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 GlaxoSmithKline plc.
2.8.1 GlaxoSmithKline plc. Details
2.8.2 GlaxoSmithKline plc. Major Business
2.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.8.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Bayer Healthcare AG
2.9.1 Bayer Healthcare AG Details
2.9.2 Bayer Healthcare AG Major Business
2.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.9.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 AstraZeneca plc.
2.10.1 AstraZeneca plc. Details
2.10.2 AstraZeneca plc. Major Business
2.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Alacer Corp.
2.11.1 Alacer Corp. Details
2.11.2 Alacer Corp. Major Business
2.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.11.4 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Alcon Inc.
2.12.1 Alcon Inc. Details
2.12.2 Alcon Inc. Major Business
2.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.12.4 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Alfresa Pharma Corporation
2.13.1 Alfresa Pharma Corporation Details
2.13.2 Alfresa Pharma Corporation Major Business
2.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.13.4 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Alkalon A/S
2.14.1 Alkalon A/S Details
2.14.2 Alkalon A/S Major Business
2.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.14.4 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Alliance Healthcare
2.15.1 Alliance Healthcare Details
2.15.2 Alliance Healthcare Major Business
2.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.15.4 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Allergan, Plc.
2.16.1 Allergan, Plc. Details
2.16.2 Allergan, Plc. Major Business
2.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.16.4 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Reckitt Benckiser Plc.
2.17.1 Reckitt Benckiser Plc. Details
2.17.2 Reckitt Benckiser Plc. Major Business
2.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.17.4 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Bausch & Lomb
2.18.1 Bausch & Lomb Details
2.18.2 Bausch & Lomb Major Business
2.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.18.4 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 AbbVie Inc.
2.19.1 AbbVie Inc. Details
2.19.2 AbbVie Inc. Major Business
2.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.19.4 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 The Colgate-Palmolive Company
2.20.1 The Colgate-Palmolive Company Details
2.20.2 The Colgate-Palmolive Company Major Business
2.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
2.20.4 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturer
3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Over the Counter (OTC) Drugs & Dietary Supplements
3.4 Market Concentration Rate
3.4.1 Top 3 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturer Market Share
3.4.2 Top 6 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturer Market Share
3.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Over the Counter (OTC) Drugs & Dietary Supplements Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region
4.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales in Volume by Region (2016-2026)
4.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2016-2026)
4.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2016-2026)
4.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2016-2026)
4.4 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2016-2026)
4.5 South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2016-2026)
4.6 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales in Volume by Type (2016-2026)
5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2016-2026)
5.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales in Volume by Application (2016-2026)
6.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2016-2026)
6.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2016-2026)
7.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2016-2026)
7.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
7.3.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales in Volume by Country (2016-2026)
7.3.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2016-2026)
8.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2016-2026)
8.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
8.3.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales in Volume by Country (2016-2026)
8.3.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2016-2026)
9.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2016-2026)
9.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region
9.3.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2016-2026)
10.2 South America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2016-2026)
10.3 South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
10.3.1 South America Over the Counter (OTC) Drugs & Dietary Supplements Sales in Volume by Country (2016-2026)
10.3.2 South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2016-2026)
11.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2016-2026)
11.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
11.3.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Over the Counter (OTC) Drugs & Dietary Supplements Typical Distributors
12.3 Over the Counter (OTC) Drugs & Dietary Supplements Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type, (USD Million), 2021-2026
Table 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 6. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 8. Novartis International AG Major Business
Table 9. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 10. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Roche Holding AG Basic Information, Manufacturing Base and Competitors
Table 12. Roche Holding AG Major Business
Table 13. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 14. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Merck & Co., Inc. Major Business
Table 17. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 18. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanofi S.A Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi S.A Major Business
Table 21. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 22. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 26. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 28. Gilead Sciences Major Business
Table 29. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 30. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors
Table 32. GlaxoSmithKline plc. Major Business
Table 33. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 34. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Bayer Healthcare AG Basic Information, Manufacturing Base and Competitors
Table 36. Bayer Healthcare AG Major Business
Table 37. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 38. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. AstraZeneca plc. Basic Information, Manufacturing Base and Competitors
Table 40. AstraZeneca plc. Major Business
Table 41. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 42. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Alacer Corp. Basic Information, Manufacturing Base and Competitors
Table 44. Alacer Corp. Major Business
Table 45. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 46. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Alcon Inc. Basic Information, Manufacturing Base and Competitors
Table 48. Alcon Inc. Major Business
Table 49. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 50. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Alfresa Pharma Corporation Basic Information, Manufacturing Base and Competitors
Table 52. Alfresa Pharma Corporation Major Business
Table 53. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 54. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Alkalon A/S Basic Information, Manufacturing Base and Competitors
Table 56. Alkalon A/S Major Business
Table 57. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 58. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Alliance Healthcare Basic Information, Manufacturing Base and Competitors
Table 60. Alliance Healthcare Major Business
Table 61. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 62. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Allergan, Plc. Basic Information, Manufacturing Base and Competitors
Table 64. Allergan, Plc. Major Business
Table 65. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 66. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Reckitt Benckiser Plc. Basic Information, Manufacturing Base and Competitors
Table 68. Reckitt Benckiser Plc. Major Business
Table 69. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 70. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Bausch & Lomb Basic Information, Manufacturing Base and Competitors
Table 72. Bausch & Lomb Major Business
Table 73. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 74. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. AbbVie Inc. Basic Information, Manufacturing Base and Competitors
Table 76. AbbVie Inc. Major Business
Table 77. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 78. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. The Colgate-Palmolive Company Basic Information, Manufacturing Base and Competitors
Table 80. The Colgate-Palmolive Company Major Business
Table 81. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product and Services
Table 82. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturer (2019-2021e) & (K MT)
Table 84. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 85. Market Position of Manufacturers in Over the Counter (OTC) Drugs & Dietary Supplements, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 86. Global Over the Counter (OTC) Drugs & Dietary Supplements Production Capacity by Company, (K MT): 2020 VS 2021
Table 87. Head Office and Over the Counter (OTC) Drugs & Dietary Supplements Production Site of Key Manufacturer
Table 88. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region (2016-2021e) & (K MT)
Table 89. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region (2021-2026) & (K MT)
Table 90. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2016-2021e) & (USD Million)
Table 91. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2021-2026) & (USD Million)
Table 92. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2016-2021e) & (K MT)
Table 93. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2021-2026) & (K MT)
Table 94. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2016-2021e) & (USD Million)
Table 95. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2021-2026) & (USD Million)
Table 96. Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Type (2016-2021e) & (USD/MT)
Table 97. Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Type (2021-2026) & (USD/MT)
Table 98. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2016-2021e) & (K MT)
Table 99. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2021-2026) & (K MT)
Table 100. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2016-2021e) & (USD Million)
Table 101. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2021-2026) & (USD Million)
Table 102. Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Application (2016-2021e) & (USD/MT)
Table 103. Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Application (2021-2026) & (USD/MT)
Table 104. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2016-2021e) & (K MT)
Table 105. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2021-2026) & (K MT)
Table 106. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2016-2021e) & (USD Million)
Table 107. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021-2026) & (USD Million)
Table 108. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2016-2021e) & (K MT)
Table 109. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2021-2026) & (K MT)
Table 110. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2016-2021e) & (K MT)
Table 111. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2021-2026) & (K MT)
Table 112. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2016-2021e) & (K MT)
Table 113. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2021-2026) & (K MT)
Table 114. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2016-2021e) & (USD Million)
Table 115. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021-2026) & (USD Million)
Table 116. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2016-2021e) & (K MT)
Table 117. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2021-2026) & (K MT)
Table 118. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2016-2021e) & (K MT)
Table 119. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2021-2026) & (K MT)
Table 120. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region (2016-2021e) & (K MT)
Table 121. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region (2021-2026) & (K MT)
Table 122. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2016-2021e) & (USD Million)
Table 123. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2021-2026) & (USD Million)
Table 124. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2016-2021e) & (K MT)
Table 125. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2021-2026) & (K MT)
Table 126. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2016-2021e) & (K MT)
Table 127. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2021-2026) & (K MT)
Table 128. South America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2016-2021e) & (K MT)
Table 129. South America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2021-2026) & (K MT)
Table 130. South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2016-2021e) & (USD Million)
Table 131. South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021-2026) & (USD Million)
Table 132. South America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2016-2021e) & (K MT)
Table 133. South America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2021-2026) & (K MT)
Table 134. South America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2016-2021e) & (K MT)
Table 135. South America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2021-2026) & (K MT)
Table 136. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2016-2021e) & (K MT)
Table 137. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2021-2026) & (K MT)
Table 138. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2016-2021e) & (USD Million)
Table 139. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2021-2026) & (USD Million)
Table 140. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2016-2021e) & (K MT)
Table 141. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2021-2026) & (K MT)
Table 142. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2016-2021e) & (K MT)
Table 143. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2021-2026) & (K MT)
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Over the Counter (OTC) Drugs & Dietary Supplements Typical Distributors
Table 147. Over the Counter (OTC) Drugs & Dietary Supplements Typical Customers
List of Figures
Figure 1. Over the Counter (OTC) Drugs & Dietary Supplements Picture
Figure 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type in 2020
Figure 3. Analgesic & pain relievers
Figure 4. Dermatological products
Figure 5. Cough, cold, and flu products
Figure 6. Vitamin supplements
Figure 7. Mineral Supplements
Figure 8. Ophthalmic Products
Figure 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application in 2020
Figure 10. Pharmacies
Figure 11. Grocery Stores
Figure 12. Vitamin
Figure 13. Health Food Stores
Figure 14. Online Pharmacies
Figure 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. United States Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Canada Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Germany Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. France Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. United Kingdom Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Russia Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Italy Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. China Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Korea Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. India Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Australia Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Egypt Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. South Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales (2016-2026) & (K MT)
Figure 37. Global Over the Counter (OTC) Drugs & Dietary Supplements Production Capacity (2016-2026) & (K MT)
Figure 38. Global Over the Counter (OTC) Drugs & Dietary Supplements Production Capacity by Geographic Region: 2020 VS 2021
Figure 39. Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
Figure 40. Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
Figure 41. Over the Counter (OTC) Drugs & Dietary Supplements Market Trends
Figure 42. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Manufacturer in 2020
Figure 43. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Manufacturer in 2020
Figure 44. Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 45. Top 3 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturer (Revenue) Market Share in 2020
Figure 46. Top 6 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturer (Revenue) Market Share in 2020
Figure 47. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region (2016-2026)
Figure 48. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region (2016-2026)
Figure 49. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2016-2026) & (USD Million)
Figure 50. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2016-2026) & (USD Million)
Figure 52. South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2016-2026) & (USD Million)
Figure 53. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue (2016-2026) & (USD Million)
Figure 54. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2016-2026)
Figure 55. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2016-2026)
Figure 56. Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Type (2016-2026) & (USD/MT)
Figure 57. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2016-2026)
Figure 58. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2016-2026)
Figure 59. Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Application (2016-2026) & (USD/MT)
Figure 60. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2016-2026)
Figure 61. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2016-2026)
Figure 62. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2016-2026)
Figure 63. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2016-2026)
Figure 64. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2016-2026)
Figure 65. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2016-2026)
Figure 66. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2016-2026)
Figure 67. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2016-2026)
Figure 72. South America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2016-2026)
Figure 73. South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2016-2026)
Figure 74. South America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2016-2026)
Figure 75. South America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2016-2026)
Figure 79. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2016-2026)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source